Table 4.
Inverse-distance weighting | Quadratic decay | |||||
---|---|---|---|---|---|---|
Cancer | Cases (n) | OR* | OR** | Cases (n) | OR* | OR** |
Hematopoietic cancers | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 233 | 1.03 | 0.99 (0.87, 1.14) | 219 | 0.97 | 0.93 (0.81, 1.06) |
High | 223 | 1.03 | 0.99 (0.86, 1.14) | 237 | 1.09 | 1.06 (0.93, 1.22) |
Leukemias | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 214 | 1.04 | 1.02 (0.88, 1.17) | 199 | 0.97 | 0.94 (0.81, 1.09) |
High | 194 | 1.00 | 0.96 (0.83, 1.12) | 209 | 1.08 | 1.05 (0.91, 1.21) |
ALL | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 184 | 1.06 | 1.05 (0.90, 1.22) | 171 | 0.99 | 0.97 (0.83, 1.13) |
High | 153 | 0.93 | 0.88 (0.75, 1.04) | 166 | 1.00 | 0.97 (0.82, 1.14) |
AML | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 24 | 0.93 | 0.90 (0.59, 1.35) | 21 | 0.81 | 0.78 (0.50, 1.21) |
High | 33 | 1.46 | 1.46 (1.01, 2.11) | 36 | 1.59 | 1.61 (1.13, 2.28) |
Lymphomas | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 19 | 0.97 | 0.78 (0.49, 1.24) | 20 | 1.00 | 0.81 (0.52, 1.28) |
High | 29 | 1.24 | 1.25 (0.85, 1.85) | 28 | 1.21 | 1.22 (0.82, 1.81) |
Non-Hodgkin’s Lymphoma | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 3 | 0.50 | N/A | 3 | 0.38 | N/A |
High | 8 | 1.37 | N/A | 8 | 1.49 | N/A |
CNS tumors | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 93 | 0.99 | 1.04 (0.84, 1.29) | 94 | 1.00 | 1.05 (0.85, 1.29) |
High | 89 | 0.99 | 1.09 (0.87, 1.36) | 88 | 0.99 | 1.08 (0.87, 1.35) |
Ependymoma | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 9 | 1.06 | N/A | 6 | 0.82 | N/A |
High | 8 | 0.78 | N/A | 11 | 1.04 | 1.34 (0.71, 2.50) |
Astrocytoma | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 35 | 0.84 | 0.89 (0.64, 1.26) | 36 | 0.84 | 0.91 (0.65, 1.28) |
High | 37 | 0.90 | 1.01 (0.72, 1.41) | 36 | 0.90 | 0.99 (0.70, 1.39) |
Neuroblastoma | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 47 | 0.87 | 0.89 (0.66, 1.19) | 52 | 0.94 | 0.98 (0.74, 1.29) |
High | 45 | 0.89 | 0.95 (0.70, 1.29) | 40 | 0.82 | 0.85 (0.61, 1.17) |
Retinoblastoma | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 32 | 1.05 | 1.05 (0.73, 1.51) | 35 | 1.15 | 1.14 (0.81, 1.62) |
High | 28 | 1.18 | 1.03 (0.69, 1.52) | 25 | 1.08 | 0.92 (0.61, 1.39) |
Unilateral RB | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 22 | 1.03 | 1.03 (0.67, 1.60) | 24 | 1.12 | 1.12 (0.74, 1.70) |
High | 18 | 1.05 | 0.93 (0.57, 1.51) | 16 | 0.96 | 0.83 (0.50, 1.38) |
Bilateral RB | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 10 | 1.13 | 1.10 (0.58, 2.10) | 11 | 1.25 | 1.21 (0.65, 2.24) |
High | 10 | 1.53 | 1.25 (0.64, 2.41) | 9 | 1.40 | N/A |
Wilms tumor | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 41 | 0.99 | 1.03 (0.75, 1.41) | 42 | 1.03 | 1.05 (0.76, 1.44) |
High | 26 | 0.88 | 0.72 (0.48, 1.07) | 25 | 0.84 | 0.69 (0.46, 1.04) |
Hepatoblastoma | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 14 | 1.05 | 1.19 (0.69, 2.05) | 14 | 1.05 | 1.19 (0.69, 2.05) |
High | 10 | 1.22 | 1.13 (0.59, 2.16) | 10 | 1.22 | 1.13 (0.59, 2.17) |
Soft Tissue sarcomas | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 31 | 1.09 | 1.19 (0.83, 1.72) | 35 | 1.21 | 1.33 (0.94, 1.89) |
High | 26 | 1.05 | 1.13 (0.75, 1.70) | 22 | 0.92 | 0.96 (0.62, 1.49) |
Germ Cell tumors | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 28 | 1.85 | 1.62 (1.09, 2.40) | 31 | 2.01 | 1.78 (1.22, 2.60) |
High | 22 | 1.51 | 1.41 (0.90, 2.21) | 19 | 1.34 | 1.22 (0.75, 1.96) |
Yolk Sac tumors | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 11 | 1.67 | 1.50 (0.80, 2.80) | 12 | 1.79 | 1.63 (0.89, 2.98) |
High | 5 | 1.14 | N/A | 4 | 1.01 | N/A |
Teratomas | ||||||
No exposure | 1.00 | Ref | 1.00 | Ref | ||
Low | 16 | 2.29 | 2.06 (1.22, 3.48) | 17 | 2.42 | 2.18 (1.30, 3.64) |
High | 15 | 2.17 | 2.10 (1.20, 3.67) | 14 | 2.02 | 1.96 (1.10, 3.47) |
Adjusted for matching factor only (birth year)
Adjusted for birth year, SES, mother’s age, mother’s education, rural/urban status, and child’s sex